TESTOMED U 250 - Deus Medical

Testosterone Undecanoate (released under name Nebido) was introduced by pharmaceutical company "Schering AG" in the early 2000s as a long-acting testosterone ester for TRT (testosterone replacement therapy). The main advantage is the extended release of testosterone, which allows users to initiate injections every ten - fourteen weeks. This extended action is due to the undecanoate ester attached to the testosterone molecule, providing a slow and consistent release into the bloodstream. Nebido became famous in Europe and other regions such an Brazil for its practicality in maintaining testosterone lvl with less amount of injections. It is good for those, who prefer a longer interval between injections, reducing the inconvenience and discomfort associated with more frequent treatments.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about TESTOMED U 250 by Deus Medical, consult with your doctor or healthcare professional.